共 45 条
- [23] Patient Controlled, Off-label Use of Continuous Glucose Monitoring: Real-World Medical Costs and Effects of Patient Controlled Sensor Augmented Pump Therapy in Adult Patients Type 1 Diabetes JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2021, 15 (03): : 575 - 581
- [27] Reply to Letter by Alexander Seibold on "Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices" by Yannis Preau, et al. (doi: 10.1089/dia.2020.0674) DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (08) : 598 - 600
- [29] A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study) JOURNAL OF DIABETES RESEARCH, 2024, 2024